NET Cancer Day
Nov 9 2012
Much has been written about a potential new treatment for neuroendocrine tumors being developed by Dr. Kjell Oberg’s team at Uppsala University Hospital in Sweden – a treatment which uses customized (i.e. molecularly engineered) viruses to target NET cancer tumor cells. The story has been covered in the mainstream media under headlines such as “A Virus That Kills Cancer: A Cure That’s Waiting In The Cold.”
On November 2, the Carcinoid & Neuroendocrine Tumor Society of Singapore held a seminar on the subject of Oncolytic Virus Therapy for Neuroendocrine Tumors (NETs). In this talk, Dr. Oberg describes and illustrates exactly how the virus is developed, how it is targeted to NET cancer tumors, and the potential benefit to patients.
Below is a link to a recording of this important, if somewhat technical, seminar.
To learn more about the oncolytic virus fund at Uppsala University click here.